Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,685,906
+$4,402 QoQ
Shares Held
20,902
-6.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,404
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ancora Advisors LLC holds $96,816,715 across 11 Drug Manufacturers - General names. MRK ranks #5 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
229,968 | $58,404,972 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
121,465 | $15,345,887 | |
| 3 | AMGN |
Amgen Inc
|
34,637 | $12,542,749 | |
| 4 | LLY |
ELI LILLY & Co
|
3,182 | $3,816,586 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
20,902 | $2,685,906 | |
| 6 | PFE |
Pfizer Inc
|
88,780 | $2,137,822 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,068 | $1,386,797 | |
| 8 | NVS |
Novartis AG
|
2,086 | $326,917 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,685,906 | 20,902 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,681,504 | 22,292 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,387,716 | 22,684 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,980,075 | 23,592 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,143,414 | 27,077 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,585,446 | 28,804 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,795,486 | 28,101 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,397,715 | 29,920 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,522,346 | 44,607 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,857,920 | 44,395 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $4,991,698 | 45,787 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,555,537 | 44,250 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,070,351 | 43,941 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,463,166 | 41,951 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $4,639,484 | 41,816 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,579,749 | 41,567 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,932,890 | 43,138 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,577,544 | 43,602 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,459,146 | 45,135 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,371,312 | 44,885 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,483,239 | 44,789 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $3,588,541 | 46,550 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $3,664,147 | 44,794 | Shares | Sole | 2021-11-12 | |
| 2020-09-30 | $3,691,193 | 44,499 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $3,505,215 | 45,328 | Shares | Sole | 2021-11-12 | |
| 2020-03-31 | $3,469,530 | 45,094 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||